Interhospital Variability in Drug Prescription after Acute Coronary Syndrome: Insights from the ACDC Study;Variabilidad interhospitalaria en la prescripción tras un síndrome coronario agudo: hallazgos del estudio ACDC

Revista Espanola de Cardiologia

Volumn 69, Issue 2, 2016, Pages 117-124

  Ferreira González, Ignacio ^a   Carrillo, Xavier ^b   Martín, Victoria ^c   De La Torre Hernández, José M ^d   Baz, José Antonio ^e   Navarro Manchón, Josep ^f   Masotti, Mónica ^g   Cequier, Ángel ^h   Cárdenas, Mérida ⁱ   Alfonso Manterola, Fernando ^j  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e HOSPITAL DO MEIXOEIRO   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ HOSPITAL JOSEP TRUETA   (Spain)

^j HOSPITAL CLÍNICO SAN CARLOS   (Spain)

more..

Author keywords

Acute coronary syndrome; Polypill; Variability in prescribing

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MULTICENTER STUDY; POLYPHARMACY; PRESCRIPTION; PROGNOSIS; RISK ASSESSMENT; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; FEMALE; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; TREATMENT OUTCOME;

EID: 84958916445     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2015.04.018     Document Type: Article

References (22)

1. C.B. Granger, P.G. Steg, E. Peterson, J. López-Sendón, W.F. Van de, E. Kline-Rogers, and et al. Medication performance measures and mortality following acute coronary syndromes Am J Med. 118 2005 858 865
2. S. Setoguchi, R.J. Glynn, J. Avorn, M.A. Mittleman, R. Levin, and W.C. Winkelmayer Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis J Am Coll Cardiol. 51 2008 1247 1254
3. D. Mukherjee, J. Fang, S. Chetcuti, M. Moscucci, E. Kline-Rogers, and K.A. Eagle Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes Circulation. 109 2004 745 749
4. A.M. Rogers, V.S. Ramanath, M. Grzybowski, A.L. Riba, S.M. Jani, R. Mehta, and et al. The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) initiative in Michigan Am Heart J. 154 2007 461 469
5. U. Zeymer, C. Junger, R. Zahn, T. Bauer, K. Bestehorn, J. Senges, and et al. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach Curr Med Res Opin. 27 2011 1563 1570
6. A.J. Bagnall, A.T. Yan, R.T. Yan, C.H. Lee, M. Tan, C. Baer, and et al. Optimal medical therapy for non - ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge Circ Cardiovasc Qual Outcomes. 3 2010 530 537
7. M. Komajda, P. Lapuerta, N. Hermans, J.R. Gonzalez-Juanatey, D.J. Van Veldhuisen, E. Erdmann, and et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey Eur Heart J. 26 2005 1653 1659
8. S. Bangalore, G. Kamalakkannan, S. Parkar, and F.H. Messerli Fixed-dose combinations improve medication compliance: a meta-analysis Am J Med. 120 2007 713 719
9. M.D. Huffman, and S. Yusuf Polypills: essential medicines for cardiovascular disease secondary prevention? J Am Coll Cardiol. 63 2014 1368 1370
10. I. Ferreira-González, J.R. Marsal, A. Ribera, G. Permanyer-Miralda, B. García-Del Blanco, G. Martí, and et al. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation Circulation. 122 2010 1017 1025
11. I. Ferreira-González, J.R. Marsal, A. Ribera, G. Permanyer-Miralda, B. García-Del Blanco, G. Martí, and et al. Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year J Am Coll Cardiol. 60 2012 1333 1339
12. A. Ribera, I. Ferreira-González, B. García del Blanco, J.R. Marsal, P. Cascant, G. Martí, and et al. Drug-eluting stents for off-label indications in real clinical world: evidence based or 'intuition' based clinical practice? Int J Cardiol. 164 2013 116 122
13. P.C. Austin Estimating multilevel logistic regression models when the number of clusters is low: a comparison of different statistical software procedures Int J Biostat. 6 2010 Article 16
14. J. Merlo, B. Chaix, H. Ohlsson, A. Beckman, K. Johnell, P. Hjerpe, and et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena J Epidemiol Community Health. 60 2006 290 297
15. W.F. Van de, D. Ardissino, H. Bueno, J.P. Collet, A. Gershlick, P. Kolh, and et al. Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines Expert Rev Cardiovasc Ther. 10 2012 489 503
16. X. Bosch, A. Sambola, F. Arós, L. López-Bescós, X. Mancisidor, J. Illa, and et al. Utilización de la trombólisis en los pacientes con infarto agudo de miocardio en España: observaciones del estudio PRIAMHO Rev Esp Cardiol. 53 2000 490 501
17. I. Ferreira-González, G. Permanyer-Miralda, J. Marrugat, M. Heras, J. Cuñat, E. Civeira, and et al. Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado). Resultados globales Rev Esp Cardiol. 61 2008 803 816
18. J.A. Barrabés, A. Bardají, J. Jiménez-Candil, F. Del Nogal Sáez, V. Bodí, N. Basterra, and et al. Pronóstico y manejo del síndrome coronario agudo en España en 2012: estudio DIOCLES Rev Esp Cardiol. 68 2015 98 106
19. M. Fiol, A. Cabadés, J. Sala, J. Marrugat, R. Elosua, G. Vega, and et al. Variabilidad en el manejo hospitalario del infarto agudo de miocardio en España. Estudio IBERICA (Investigación, Búsqueda Específica y Registro de Isquemia Coronaria Aguda) Rev Esp Cardiol. 54 2001 443 452
20. J.M. Ruiz-Nodar, A. Cequier, T. Lozano, F. Fernández Vázquez, I. Möller, S. Abán, and et al. Impacto del tipo de hospital en el tratamiento y evolución de los pacientes con síndrome coronario agudo sin elevación del ST Rev Esp Cardiol. 63 2010 390 399
21. V. Bertomeu, A. Cequier, J.L. Bernal, F. Alfonso, M.P. Anguita, J. Muñiz, and et al. Mortalidad intrahospitalaria por infarto agudo de miocardio. Relevancia del tipo de hospital y la atención dispensada. Estudio RECALCAR Rev Esp Cardiol. 66 2013 935 942
22. T. Oliveras Vilà, M. Ferrer Massot, A. Curós Abadal, F. Rueda Sobella, J. Serra Flores, X. Carrillo Suárez, and et al. Real-life use of the polypill components (ASA + ACEI + statins) after an acute coronary syndrome and long-term mortality Int J Cardiol. 177 2014 209 210